Gland Pharma Appoints Shyamakant Giri as CEO
Gland Pharma has appointed Shyamakant Giri as its new CEO, effective January 15, 2025. Giri currently serves as President of Amneal Pharmaceuticals.
New Delhi, Oct 18 (PTI) Gland Pharma on Friday said its board has appointed Shyamakant Giri as CEO with effect from January 15, 2025.
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals, responsible for the commercial expansion and growth in India and Rest of the World markets.
Srinivas Sadu will continue to be the executive chairman of the company and support its next phase of growth, Gland Pharma said.
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals, responsible for the commercial expansion and growth in India and Rest of the World markets.
Srinivas Sadu will continue to be the executive chairman of the company and support its next phase of growth, Gland Pharma said.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 6.72 ( -8.82)
- 176950497
- Standard Capital
- 0.38 ( -2.56)
- 51073513
- Harshil Agrotech
- 2.38 (+ 4.85)
- 27813022
- AvanceTechnologies
- 0.76 (+ 15.15)
- 27508699
- G G Engineering
- 0.71 ( -4.05)
- 18755811
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback